GSK plc (GSK) Nuvalent, Inc. - M&A Call - Slideshow
Developing story — details emerging. Check the source link for the latest updates.
🏷️ #gsk
4 headlinesGSK Just Dropped $10.6 Billion on a Lung Cancer Bet
Developing story — details emerging. Check the source link for the latest updates.
GSK makes biggest ever acquisition with $10.6bn for US cancer drug firm
Nuvalent’s late-stage lung cancer treatments zidesamtinib and neladalkib are expected to launch later this year Business live – latest updates GSK’s new boss, Luke Miels , has struck one of the British drugmaker’s biggest deals, announcing the $10. 6bn (£7. 9bn) acquisition of a US cancer special...
Nuvalent shares surge 39% after UK's GSK agrees to buy the cancer drugmaker for $10.6 billion
The deal comes at a time of biotech dealmaking frenzy, driven by looming patent cliffs, newly buoyant public markets and drugmakers' race to bolster pipelines.